{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:05:58Z","timestamp":1793736358017,"version":"4.6.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>A scoping review found that most studies on women\u2019s health in multiple sclerosis (MS) focused on pregnancy, fetal\/neonatal outcomes and sexual dysfunction. Few studies addressed menopause, contraception, gynecologic cancers\/cancer screening. However, the perceived relative importance of these knowledge gaps to people living with MS and other partners is unknown. We engaged a range of partners, including people living with MS, health care providers, researchers, and patient advocacy groups, to set priorities for future research in women\u2019s health in MS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We employed a three-step global engagement process. First, we identified which broad research topics relevant to women\u2019s health in MS were of highest priority using two surveys. Second, we developed specific research questions within these topics using focus groups. Finally, we prioritized the research questions with a third survey.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 5,266 individuals responded to the initial surveys [<jats:italic>n<\/jats:italic>\u2009=\u20091,430 global survey, mean (SD) age 50.0 (12.6), all continents; <jats:italic>n<\/jats:italic>\u2009=\u20093,836 North American Research Committee on Multiple Sclerosis survey, mean (SD) age 64.8 (9.6), United States]. Menopause, sexual dysfunction, pregnancy, gynecologic cancer\/cancer screening, hormones and parenthood were identified as the most important topics. Focus groups generated 80 potential research questions related to these topics. In the final survey 712 individuals prioritized these questions. The highest priority questions in each research topic were: (i) How do perimenopause and menopause affect disease activity, course, response to disease-modifying treatment and quality of life in MS; (ii) What are the most effective strategies for managing issues around sexual intimacy, including related to low sexual desire, changes in physical function, and MS symptoms; (iii) Are there long-term effects of disease-modifying therapies on the children of persons with MS; (iv) What are the short and long-term effects of disease-modifying drugs on gynecologic cancer risk, particularly for high efficacy disease-modifying drugs and hematopoietic stem cell transplantation; (v) Are there hormone related treatments that can stabilize fluctuations in MS symptoms; and (vi) How does MS fatigue impact parenting strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Priorities for research relating to women\u2019s health issues for persons with MS have been delineated using a collaborative process with key partners. Alignment of future research with these priorities should be monitored.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1355817","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T04:57:51Z","timestamp":1708318671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Priority setting: women\u2019s health topics in multiple sclerosis"],"prefix":"10.3389","volume":"15","author":[{"given":"Lindsay","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Finlayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey Alan","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Hellwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Tintore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Vukusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Salter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"ref1","first-page":"1816","volume-title":"Mult. scler. J.","author":"Walton","year":"2020"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"812147","DOI":"10.3389\/fneur.2021.812147","article-title":"Women\u2019s health in multiple sclerosis: a scoping review","volume":"12","author":"Ross","year":"2021","journal-title":"Front Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12905-023-02501-1","article-title":"Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis","volume":"23","author":"Yazdani","year":"2023","journal-title":"BMC Womens Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e0193579","DOI":"10.1371\/journal.pone.0193579","article-title":"Patient and public engagement in priority setting: a systematic rapid review of the literature","volume":"13","author":"Manaf\u00f2","year":"2018","journal-title":"PLoS One"},{"key":"ref5","volume-title":"The James Lind Alliance guidebook","author":"Cowan","year":"2013"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7224\/1537-2073.2020-133","article-title":"NARCOMS and other registries in multiple sclerosis: issues and insights","volume":"23","author":"Marrie","year":"2021","journal-title":"Int J MS Care"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7224\/1537-2073.2021-102","article-title":"A systematic review of the validity and reliability of the patient-determined disease steps scale","volume":"25","author":"Marrie","year":"2022","journal-title":"Int J MS Care"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1212\/wnl.0000000000003831","article-title":"High hypothetical interest in physician-assisted death in multiple sclerosis","volume":"88","author":"Marrie","year":"2017","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/s0140-6736(00)02351-5","article-title":"Relation between agendas of the research community and the research consumer","volume":"355","author":"Tallon","year":"2000","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/ane.12881","article-title":"Perceptions on the value of bodily functions in multiple sclerosis","volume":"137","author":"Heesen","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s40273-016-0435-7","article-title":"Assessing the value of treatment to address various symptoms associated with multiple sclerosis: results from a contingent valuation study","volume":"34","author":"Lin","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.msard.2017.11.013","article-title":"Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: a combined perspective from the MS in the 21st century steering group","volume":"19","author":"Rieckmann","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1471-2377-13-177","article-title":"What do multiple sclerosis patients and their caregivers perceive as unmet needs?","volume":"13","author":"Lorefice","year":"2013","journal-title":"BMC Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.17925\/USN.2015.11.02.80","article-title":"Your patients with multiple sclerosis have set wellness as a high priority-and the national multiple sclerosis society is responding","volume":"11","author":"Dunn","year":"2015","journal-title":"US Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ygyno.2016.08.333","article-title":"Working together to shape the endometrial cancer research agenda: the top ten unanswered research questions","volume":"143","author":"Wan","year":"2016","journal-title":"Gynecol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e016571","DOI":"10.1136\/bmjopen-2017-016571","article-title":"Priorities for research in miscarriage: a priority setting partnership between people affected by miscarriage and professionals following the James Lind Alliance methodology","volume":"7","author":"Prior","year":"2017","journal-title":"BMJ Open"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/uog.15738","article-title":"Research priorities for stillbirth: process overview and results from UK stillbirth priority setting partnership","volume":"46","author":"Heazell","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1177\/0300060517746026","article-title":"Effects of multiple sclerosis and medications on menopausal age","volume":"46","author":"T\u00fcrk B\u00f6r\u00fc","year":"2018","journal-title":"J Int Med Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/014107689208501008","article-title":"A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle","volume":"85","author":"Smith","year":"1992","journal-title":"J R Soc Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000496374","article-title":"The influence of menopause in multiple sclerosis course: a longitudinal cohort study","volume":"80","author":"Ladeira","year":"2018","journal-title":"Eur Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1177\/1352458515606211","article-title":"Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort","volume":"22","author":"Bove","year":"2016","journal-title":"Mult Scler"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.msard.2014.11.009","article-title":"Patients report worse MS symptoms after menopause: findings from an online cohort","volume":"4","author":"Bove","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1136\/jnnp-2019-320587","article-title":"Impact of natural menopause on multiple sclerosis: a multicentre study","volume":"90","author":"Baroncini","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12883-023-03332-1","article-title":"Impact of menopause on relapse rate and disability level in patients with multiple sclerosis (MS): a systematic review and meta-analysis","volume":"23","author":"Shahraki","year":"2023","journal-title":"BMC Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/ene.14782","article-title":"Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset","volume":"29","author":"Otero-Romero","year":"2022","journal-title":"Eur J Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1212\/WNL.0000000000004843","article-title":"Ovarian aging is associated with gray matter volume and disability in women with MS","volume":"90","author":"Graves","year":"2018","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1251667","DOI":"10.3389\/fneur.2023.1251667","article-title":"Menopausal transition in multiple sclerosis: relationship with disease activity and brain volume measurements","volume":"14","author":"Lorefice","year":"2023","journal-title":"Front Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.msard.2016.06.015","article-title":"Women\u2019s experiences of menopause in an online MS cohort: a case series","volume":"9","author":"Bove","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40900-019-0159-x","article-title":"Adapting the James Lind Alliance priority setting process to better support patient participation: an example from cystic fibrosis","volume":"5","author":"Rowbotham","year":"2019","journal-title":"Res Involv Engagem"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","article-title":"Population-based estimates for the prevalence of multiple sclerosis in the United States by race, ethnicity, age, sex, and geographic region","volume":"80","author":"Hittle","year":"2023","journal-title":"JAMA Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1355817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T04:57:54Z","timestamp":1708318674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1355817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":31,"alternative-id":["10.3389\/fneur.2024.1355817"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1355817","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,19]]},"article-number":"1355817"}}